Gossamer Bio, Inc. (GOSS)
NASDAQ · Manufacturing · Pharmaceutical preparations
$10.94+$0.0100 (+0.09%) on the dayAs of the close; data may be delayed.
GOSS price, last 12 months
Key stats
- Previous close
- $10.93
- Open
- $10.93
- Day range
- $10.22 – $11.01
- 52-week range
- $9.10 – $309.60
- Volume
- 426.6K
- Avg volume (20 days)
- 238.7K
- Market cap
- $66.9M
Performance
1W+2.0%
1M−21.4%
3M−12.9%
6M−63.5%
YTD−95.6%
1Y−95.4%
vs S&P 500, 1Y−112.2 pts
Technicals and fundamentals
About Gossamer Bio, Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $66.9M